Newsroom

News

Hepatitis B is a viral infection of the liver that can lead to cancer and organ failure. Antiviral therapies can suppress the infection, but a functional cure is rare. Novel immunotherapies may lead to an actual cure more often. However, it is still unclear which patients benefit most from these new therapies. Researchers at the Centre for Individualised Infection Medicine (CiiM), a joint institution of the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH), as well as the MHH and the German Center for Infection Research (DZIF), have now identified a biomarker that intends to enable predictions about the success of the therapy. The results were published in the scientific journal Gut.

25.11.2021

CiiM

News

The Helmholtz Centre for Infection Research (HZI) in Braunschweig and the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) at McGill University in Montréal, Canada, are organising a joint symposium on personalised infection medicine on 29 November. Three researchers from each of the two institutions will give lectures on various topics of personalised infection medicine. The keynote lecture will be given by Prof Ugur Sahin, co-founder and CEO of BioNTech SE. The symposium kicks off McGill University's “Infection and Immunity Week”, which celebrates its 200th anniversary this year. Interested scientists can register to follow the event online.

23.11.2021

HZI Campus

CiiM

HIRI

News

Ahead of the “World Antimicrobial Awareness Week” (November 18-24) 20 national and international organizations from academia, healthcare and the pharmaceutical industry appealed today to G7 governments to step up efforts to tackle the problem of growing antibiotic resistance. Their "Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation" stresses that only an approach involving both the public and private sectors is likely to succeed. The Helmholtz Centre for Infection Research (HZI) is a member of the Helmholtz Association of German Research Centres and the German Center for Infection Research (DZIF), which both signed the statement.

17.11.2021

HZI Campus

News

Researchers from the Helmholtz Centre for Infection Research (HZI) and partners from the University of Bordeaux have established a mechanism that regulates the migration of individual cells. The study was recently published in Nature Cell Biology and discussed in an accompanying article by renowned experts.

16.11.2021

HZI Campus

Illustration von antiviralen Wirkstoffen

News

The Federal Agency for Disruptive Innovation (SPRIND) has announced the participants of the first SPRIND Challenge “A Quantum Leap for New Antiviral Agents”. From 45 applications from Germany and Europe, the jury selected a total of nine teams. Prof Mark Brönstrup from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Prof Chase Beisel from the Helmholtz Institute for RNA-based Infection Research (HIRI), a joint institution of the HZI with the Julius-Maximilians-Universität Würzburg (JMU), convinced the jury with the projects they led. The HZI scientists Prof Carlos A. Guzmán and Dr Christian Sieben are involved in two other projects as cooperation partners. The teams will each receive up to 700,000 euros in the first year of the three-year competition to develop new drug candidates against viral diseases.

10.11.2021

HZI Campus

HIPS

HIRI

News

The Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) is supporting the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg - an institution of the Helmholtz Centre for Infection Research Braunschweig in cooperation with the Julius-Maximilians-University - with up to 733,000 euros. The grant is awarded to Daphne Collias, a post-doc in Chase Beisel’s lab at HIRI, to take the new and award-winning LEOPARD technology a decisive step further towards commercialization. In the future, LEOPARD may help physicians and patients by providing more comprehensive diagnostic information about a patient’s health. The funding is part of the "GO-Bio initial" program from the BMBF and is granted for a period of 24 months.

03.11.2021

HIRI

Back to the first page
...
54
55
56
57
...
153

HZI in the media

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026

Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeutische Forschung Saarland (HIPS) ...

18.03.2026

Biermann Medizin

... Ausbau von Produktions- und Vermarktungskapazitäten.

Das Helmholtz-Zentrum für Infektionsforschung HZI begrüßt den Erhalt der GMP- ...

18.03.2026

Bionity.COM

... der Universität zu Lübeck, des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig, der Medizinischen Hochschule Hannover ...

17.03.2026

Biermann Medizin

Vorsorge Das Coronavirus hält die Welt nicht mehr in Atem. Doch was, wenn ein anderer gefährlicher Erreger auftaucht? So wappnet sich unser Gesundheitssystem

16.03.2026

Apotheken Umschau

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

14.03.2026

ARD Mediathek

... der Medizinischen Hochschule Hannover und dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig neue Wirkstoffe ...

13.03.2026

MTA Dialog

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026

Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026

Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026

NDR Norddeutscher Rundfunk

Nachwuchsgruppe „Nanoinfektionsbiologie“ am HZI. Diese Lücke soll das Projekt ONEMUC (Respiratorischer Mukus als One Health-Schnittstelle) ...

03.03.2026

DeutschesGesundheitsPortal

Hochschule Hannover (MHH) und des Helmholz-Zentrums für Infektionsforschung (HZI) erforschen im Rahmen des Projektes StopPSC ( ...

03.03.2026

Biermann Medizin

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.